These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Radiolabeled isatin binding to caspase-3 activation induced by anti-Fas antibody. Chen DL; Zhou D; Chu W; Herrbrich P; Engle JT; Griffin E; Jones LA; Rothfuss JM; Geraci M; Hotchkiss RS; Mach RH Nucl Med Biol; 2012 Jan; 39(1):137-44. PubMed ID: 22033021 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, radiolabeling, and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis. Zhou D; Chu W; Rothfuss J; Zeng C; Xu J; Jones L; Welch MJ; Mach RH Bioorg Med Chem Lett; 2006 Oct; 16(19):5041-6. PubMed ID: 16891117 [TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [18F]-labeled isatin sulfonamide. Nguyen QD; Smith G; Glaser M; Perumal M; Arstad E; Aboagye EO Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16375-80. PubMed ID: 19805307 [TBL] [Abstract][Full Text] [Related]
7. Characterization of 64Cu-DOTA-conatumumab: a PET tracer for in vivo imaging of death receptor 5. Rossin R; Kohno T; Hagooly A; Sharp T; Gliniak B; Arroll T; Chen Q; Hewig A; Kaplan-Lefko P; Friberg G; Radinsky R; Evelhoch JL; Welch MJ; Hwang DR J Nucl Med; 2011 Jun; 52(6):942-9. PubMed ID: 21571804 [TBL] [Abstract][Full Text] [Related]
8. PET imaging of in vivo caspase-3/7 activity following myocardial ischemia-reperfusion injury with the radiolabeled isatin sulfonamide analogue [(18)F]WC-4-116. Thukkani AK; Shoghi KI; Zhou D; Xu J; Chu W; Novak E; Chen DL; Gropler RJ; Mach RH Am J Nucl Med Mol Imaging; 2016; 6(2):110-9. PubMed ID: 27186438 [TBL] [Abstract][Full Text] [Related]
9. Temporal and spatial evolution of therapy-induced tumor apoptosis detected by caspase-3-selective molecular imaging. Nguyen QD; Lavdas I; Gubbins J; Smith G; Fortt R; Carroll LS; Graham MA; Aboagye EO Clin Cancer Res; 2013 Jul; 19(14):3914-24. PubMed ID: 23729364 [TBL] [Abstract][Full Text] [Related]
10. Comparison of radiolabeled isatin analogs for imaging apoptosis with positron emission tomography. Chen DL; Zhou D; Chu W; Herrbrich PE; Jones LA; Rothfuss JM; Engle JT; Geraci M; Welch MJ; Mach RH Nucl Med Biol; 2009 Aug; 36(6):651-8. PubMed ID: 19647171 [TBL] [Abstract][Full Text] [Related]
11. Preclinical assessment of carboplatin treatment efficacy in lung cancer by 18F-ICMT-11-positron emission tomography. Witney TH; Fortt R; Aboagye EO PLoS One; 2014; 9(3):e91694. PubMed ID: 24618809 [TBL] [Abstract][Full Text] [Related]
12. Clinical translation of [ Dubash SR; Merchant S; Heinzmann K; Mauri F; Lavdas I; Inglese M; Kozlowski K; Rama N; Masrour N; Steel JF; Thornton A; Lim AK; Lewanski C; Cleator S; Coombes RC; Kenny L; Aboagye EO Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2285-2299. PubMed ID: 30259091 [TBL] [Abstract][Full Text] [Related]
13. A peptide-based positron emission tomography probe for in vivo detection of caspase activity in apoptotic cells. Hight MR; Cheung YY; Nickels ML; Dawson ES; Zhao P; Saleh S; Buck JR; Tang D; Washington MK; Coffey RJ; Manning HC Clin Cancer Res; 2014 Apr; 20(8):2126-35. PubMed ID: 24573549 [TBL] [Abstract][Full Text] [Related]
14. [18F]- and [11C]-labeled N-benzyl-isatin sulfonamide analogues as PET tracers for apoptosis: synthesis, radiolabeling mechanism, and in vivo imaging study of apoptosis in Fas-treated mice using [11C]WC-98. Zhou D; Chu W; Chen DL; Wang Q; Reichert DE; Rothfuss J; D'Avignon A; Welch MJ; Mach RH Org Biomol Chem; 2009 Apr; 7(7):1337-48. PubMed ID: 19300818 [TBL] [Abstract][Full Text] [Related]
15. Imaging apoptosis with positron emission tomography: 'bench to bedside' development of the caspase-3/7 specific radiotracer [(18)F]ICMT-11. Nguyen QD; Challapalli A; Smith G; Fortt R; Aboagye EO Eur J Cancer; 2012 Mar; 48(4):432-40. PubMed ID: 22226480 [TBL] [Abstract][Full Text] [Related]
16. Preclinical Kinetic Analysis of the Caspase-3/7 PET Tracer 18F-C-SNAT: Quantifying the Changes in Blood Flow and Tumor Retention After Chemotherapy. Palner M; Shen B; Jeon J; Lin J; Chin FT; Rao J J Nucl Med; 2015 Sep; 56(9):1415-21. PubMed ID: 26045308 [TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-triggered nanoaggregation probe. Shen B; Jeon J; Palner M; Ye D; Shuhendler A; Chin FT; Rao J Angew Chem Int Ed Engl; 2013 Sep; 52(40):10511-4. PubMed ID: 23881906 [TBL] [Abstract][Full Text] [Related]
18. Fluorinated isatin derivatives. Part 3. New side-chain fluoro-functionalized pyrrolidinyl sulfonyl isatins as potent caspase-3 and -7 inhibitors. Podichetty AK; Wagner S; Faust A; Schäfers M; Schober O; Kopka K; Haufe G Future Med Chem; 2009 Aug; 1(5):969-89. PubMed ID: 21426092 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of the caspase-3 substrate-based radiotracer [(18)F]-CP18 for PET imaging of apoptosis in tumors. Xia CF; Chen G; Gangadharmath U; Gomez LF; Liang Q; Mu F; Mocharla VP; Su H; Szardenings AK; Walsh JC; Zhao T; Kolb HC Mol Imaging Biol; 2013 Dec; 15(6):748-57. PubMed ID: 23689985 [TBL] [Abstract][Full Text] [Related]
20. 18F-ICMT-11, a caspase-3-specific PET tracer for apoptosis: biodistribution and radiation dosimetry. Challapalli A; Kenny LM; Hallett WA; Kozlowski K; Tomasi G; Gudi M; Al-Nahhas A; Coombes RC; Aboagye EO J Nucl Med; 2013 Sep; 54(9):1551-6. PubMed ID: 23949910 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]